Endo's (ENDP) Weak Results/Guidance Weigh on Specialty pharma (VRX) (HZNP) (MNK)
Endo Intl's (NASDAQ: ENDP) horrendous guidance is ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
